Li-Ka, Allen, Liu is the Head of Medical at Sandoz Taiwan and Hong Kong, a position they hold in 2024. They previously served as a Medical Advisor in Oncology at Takeda from 2021 to 2022 and have held various roles at Roche, AstraZeneca, and other organizations in the medical field. Li-Ka completed their Ph.D. in Molecular, Cellular and Development Biology at the University of Rochester and obtained both a Bachelor's and Master's degree from National Taiwan University in Agricultural Chemistry and Biochemistry, respectively. Their extensive experience in medical and scientific roles underscores a strong commitment to advancing healthcare.
This person is not in any teams
This person is not in any offices